Abstract:ABSTRACT Avilamycins, which possess potent inhibitory activity against Gram-positive bacteria, are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes . Among these structurally related oligosaccharide antibiotics, avilamycin A serves as the main bioactive component in veterinary drugs and animal feed additives, which differs from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. However, the mechanisms underlying assembly and modification of the oligosaccharide chain to diversify individual avilamycins remain poorly understood. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . Remarkably, the ratio of these two components produced by AviZ1 depends on the utilization of specific redox cofactors, namely NADH/NAD + or NADPH/NADP + . These findings are inspired by gene disruption and complementation experiments and are further supported by in vitro enzymatic activity assays, kinetic analyses, and cofactor affinity studies on AviZ1-catalyzed redox reactions. Additionally, the results from sequence analysis, structure prediction, and site-directed mutagenesis of AviZ1 validate it as an NADH/NAD + -favored aldo-keto reductase that primarily oxidizes avilamycin C to form avilamycin A by utilizing abundant NAD + in vivo . Building upon the biological function and catalytic activity of AviZ1, overexpressing AviZ1 in S. viridochromogenes is thus effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study represents, to our knowledge, the first characterization of biochemical reactions involved in avilamycin biosynthesis and contributes to the construction of high-performance strains with industrial value. IMPORTANCE Avilamycins are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes , which can be used as veterinary drugs and animal feed additives. Avilamycin A is the most bioactive component, differing from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. Currently, the biosynthetic pathway of avilamycins is not clear. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . More importantly, AviZ1 exhibits a unique NADH/NAD + preference, allowing it to efficiently catalyze the oxidation of avilamycin C to form avilamycin A using abundant NAD + in cells. Thus, overexpressing AviZ1 in S. viridochromogenes is effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study serves as an enzymological guide for rational strain design, and the resulting high-performance strains have significant industrial value.

Enhanced validamycin production by addition of aromatic amino acid

Effects of Amino Acids on the Biosynthesis of Validamycin A in the Fermentation of Streptomyces Hygroscopicus 5008

Enhancement of validamycin A production by addition of ethanol in fermentation of Streptomyces hygroscopicus 5008.

Fermentation process and kinetics of novel antifungal antibiotic production

Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis

Over-expression of UDP-glucose pyrophosphorylase increases validamycin A but decreases validoxylamine A production in Streptomyces hygroscopicus var. jinggangensis 5008.

Avilamycin production enhancement by mutagenesis and fermentation optimization in Streptomyces viridochromogenes

Temperature Shift-Induced Reactive Oxygen Species Enhanced Validamycin A Production in Fermentation of Streptomyces Hygroscopicus 5008.

Impact of Nitrogen Concentration on Validamycin A Production and Related Gene Transcription in Fermentation of Streptomyces Hygroscopicus 5008

Enhanced Production Of Validamycin A By H2o2-Induced Reactive Oxygen Species In Fermentation Of Streptomyces Hygroscopicus 5008

Engineering Validamycin Production by Tandem Deletion of Γ-Butyrolactone Receptor Genes in Streptomyces Hygroscopicus 5008

Production of l-phenylalanine from glucose by metabolic engineering of wild type Escherichia coli W3110

Enhanced Production of Validamycin A in Streptomyces Hygroscopicus 5008 by Engineering Validamycin Biosynthetic Gene Cluster.

Enhanced AmB Production in Streptomyces nodosus by Fermentation Regulation and Rational Combined Feeding Strategy

Significance of Oxygen Carriers and Role of Liquid Paraffin in Improving Validamycin A Production

Screening, Characterization and Utilization of D-amino Acid Aminotransferase to Obtain D-phenylalanine

Alkaline Ph Shock Enhanced Production of Validamycin A in Fermentation of Streptomyces Hygroscopicus.

High-titer production of aromatic amines in metabolically engineered Escherichia coli

An NADH/NAD+-favored aldo-keto reductase facilitates avilamycin A biosynthesis by primarily catalyzing oxidation of avilamycin C

Effect of fermentation temperature on validamycin A production by Streptomyces hygroscopicus 5008.

Genetically Engineered Production of 1,1′-Bis-valienamine and Validienamycin in Streptomyces Hygroscopicus and Their Conversion to Valienamine